Coverage
-
November 09, 2016
A Pennsylvania federal judge ruled Wednesday that GlaxoSmithKline cannot escape a suit brought by 41 insurers over adulterated drugs from a now-defunct Puerto Rican factory, invoking a recent appellate decision that allowed union health funds to sue the drugmaker under the Racketeer Influenced and Corrupt Organizations Act.
1 other articles on this case.
View all »